Testing effectiveness (Phase 2)Enrolling By InvitationNCT07807020
What this trial is testing
This Study Aims to Determine Whether Lower Doses (4 µg) of Intrathecal Dexmedetomidine Can Provide Comparable Analgesic Benefits While Minimizing Adverse Hemodynamic Effects in Patients Encountered in Our Setup( Shifa International Hospital Islamabad).
Who this might be right for
Intrathecal Dexmedetomidine
Shifa International Hospital 60